Search for a command to run...
Promoters and Institutions decreased shareholding in Nectar Lifesciences by 11.27% and 15.93% YoY, contrasting with sector averages that remained stable.
Public shareholding increased by 4.21% YoY, indicating retail support amidst declining institutional confidence.
Nectar Lifesciences is the worst performer in the sector for Institutions, showcasing a significant loss of smart money interest.
| Category | Trend | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
1Promoter5 | 55.8% | 55.8% | 55.8% | 55.8% | 44.53% | 44.53% | 44.53% | 44.9% | |
2Institution3 | 15.93% | 15.93% | 15.86% | 1.34% | - | - | - | - | |
3Public5 | 0.05% | 0.05% | - | 3.07% | 2.13% | 4.26% | 3.08% | 1.78% |